Health Care Price Certainty for All Americans Act
Summary
HR9645, the Health Care Price Certainty for All Americans Act, would require hospitals to publicly disclose prices, including cash discounts, starting January 2027. The bill is in early committee stage and has no cosponsors. If enacted, it would pressure hospital margins by increasing price transparency, benefiting insurers and self-insured employers at the expense of hospital operators like HCA.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR9645 is a price transparency mandate for hospitals, introduced by a powerful committee chair, but early-stage and uncosponsored.
- 2.If enacted, hospital operators like HCA face margin compression, while insurers benefit from increased pricing transparency.
- 3.No funding is allocated; the bill imposes compliance costs on hospitals without direct financial incentives.
Market Implications
The immediate market reaction to the bill's introduction has been muted given its early stage. For hospital operators, the bill is a regulatory risk that compounds existing margin pressure from labor costs and utilization shifts. $HCA, with its large hospital footprint, would be the most directly affected. Insurers, particularly those with strong PBM and care management capabilities ($UNH's Optum), are positioned to benefit from price transparency tools. However, the bill's low probability of passage in its current form keeps the near-term impact limited. Investors should watch for committee hearings and any companion bill in the Senate as signals of momentum.
Full Analysis
On July 13, 2026, Rep. Jason Smith (R-MO-8) introduced HR9645, which mandates price transparency for hospitals participating in Medicare. The bill requires hospitals to publish standard charges, discounted cash prices, and prices for at least 300 shoppable services in a free, publicly accessible format, updated at least annually. It has been referred to three committees: Energy and Commerce, Ways and Means (chaired by Smith), and Education and Workforce. As a procedural early-stage bill with no cosponsors, passage remains uncertain, but the sponsor's chairmanship of Ways and Means gives it a credible path to markup.
The money trail: The bill does not authorize or appropriate new funding; it imposes a compliance mandate on hospitals. Non-compliant hospitals face no direct penalty specified in the text, but the mandate is tied to Medicare participation. The cost of compliance—IT systems, data management, and public posting—falls on hospitals. For a large operator like HCA ($60B+ revenue), the upfront cost is a minor fraction of revenue, but the structural impact of price transparency on pricing power is more significant.
Structural winners and losers: The primary losers are hospital operators that rely on opaque pricing to maintain high margins, particularly for elective procedures. $HCA, $THC, $UHS, and $CYH face margin compression as consumers and employers use price data to shop for lower-cost alternatives. Conversely, health insurers ($UNH, $CI, $HUM, $ELV) and self-insured employers gain leverage to negotiate lower rates and steer patients, potentially reducing medical cost trends. However, the bill is early stage, and price transparency has been a long-standing policy goal with limited enforcement under previous administrations. The timeline: the bill requires implementation by January 1, 2027, providing a 6-month runway. Substantial regulatory rulemaking by CMS would be needed, and the fate of the bill depends on the 119th Congress's legislative calendar. Given the narrow window before the 2026 midterm elections, passage is possible but not probable.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Mandate for hospitals participating in Medicare to disclose standard charges, discounted cash prices, and shoppable service prices in a public, machine-readable format.
Who must act
Hospitals receiving Medicare payments, including HCA Healthcare's acute care facilities.
What happens
Price transparency enables consumers and employers to compare prices, increasing price sensitivity and pressuring hospitals to lower negotiated rates and cash prices, particularly for elective and shoppable services.
Stock impact
HCA Healthcare's core hospital revenue (majority of its ~$60B+ total revenue) is exposed to potential margin compression as transparency reduces pricing power and may increase patient outmigration to lower-cost providers. Compliance costs for data systems are incremental but manageable.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →